Literature DB >> 8909657

Oophorectomy status and bone density in older, hysterectomized women.

D Kritz-Silverstein1, E Barrett-Connor.   

Abstract

INTRODUCTION: This study examined the long-term effects of hysterectomy, with and without bilateral oophorectomy, and treatment with estrogen replacement on bone mineral density in older hysterectomized women.
METHODS: Subjects were 346 women 60-89 years of age, who were participants in the Rancho Bernardo Study and attended a follow-up clinic visit in 1988-1991. Bone density was measured at the ultradistal wrist, midshaft radius, lumbar spine and hip.
RESULTS: Of these women, 182 had a hysterectomy with conservation of one or both ovaries and 164 had a hysterectomy with bilateral oophorectomy. Current estrogen users had the highest bone densities; those who never used estrogen replacement had the lowest. Only 9.1% of oophorectomized women, compared to 19.2% of those with ovarian conservation had never used estrogen (P < .01). After adjustment for covariates including estrogen replacement therapy, hysterectomized women with ovarian conservation had marginally higher bone densities at the wrist (P < .09) and spine (P < .06) than oophorectomized women. We found significant differences only among women currently using estrogen (P < .05 for wrist and P < .01 for spine densities, respectively). Bone density did not differ at any site by oophorectomy status among past or never users of estrogen.
CONCLUSIONS: Hysterectomized women who use estrogen replacement therapy have better bone density, regardless of a bilateral oophorectomy. In addition, bilateral oophorectomy may not have a long-term negative effect on bone density; hysterectomized women who do not use estrogen appear to have equivalent bone density whether or not they had a bilateral oophorectomy.

Entities:  

Mesh:

Year:  1996        PMID: 8909657

Source DB:  PubMed          Journal:  Am J Prev Med        ISSN: 0749-3797            Impact factor:   5.043


  2 in total

1.  Surgical menopause and nonvertebral fracture risk among older US women.

Authors:  Kimberly K Vesco; Lynn M Marshall; Heidi D Nelson; Linda Humphrey; Joanne Rizzo; Kathryn L Pedula; Jane A Cauley; Kristine E Ensrud; Marc C Hochberg; Diana Antoniucci; Teresa A Hillier
Journal:  Menopause       Date:  2012-05       Impact factor: 2.953

2.  Hormone therapy after the Women's Health Initiative: a qualitative study.

Authors:  Linda M French; Mindy A Smith; Jodi S Holtrop; Margaret Holmes-Rovner
Journal:  BMC Fam Pract       Date:  2006-10-23       Impact factor: 2.497

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.